We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
–
AUM
$261M
AUM Growth
+$6.96M
Cap. Flow
+$946K
Cap. Flow %
0.36%
Top 10 Hldgs %
39.48%
Holding
75
New
5
Increased
17
Reduced
28
Closed
1

Top Buys

Rank Stock Value
1
DO
Diamond Offshore Drilling
DO
+$1.67M
2
RIG icon
Transocean
RIG
+$1.5M
3
IBM icon
IBM
IBM
+$1.37M
4
QEP
QEP RESOURCES, INC.
QEP
+$1.32M
5
KEYS icon
Keysight
KEYS
+$1.18M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$5.45M
2
A icon
Agilent Technologies
A
+$1.16M
3
DNOW icon
DNOW Inc
DNOW
+$584K
4
ADP icon
Automatic Data Processing
ADP
+$491K
5
PFE icon
Pfizer
PFE
+$237K

Sector Composition

Rank Sector Weight
1 Industrials 25.54%
2 Healthcare 21.6%
3 Energy 16.6%
4 Technology 16.23%
5 Consumer Staples 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
51
Chevron
CVX
$366B
$1.4M 0.54%
12,493
+300
+2% +$34.1K
KEYS icon
52
Keysight
KEYS
$58.3B
$1.22M 0.47%
+36,115
New +$1.18M
CAT icon
53
Caterpillar
CAT
$387B
$1.2M 0.46%
13,147
-35
-0.3% -$3.41K
EW icon
54
Edwards Lifesciences
EW
$51.7B
$1.13M 0.43%
53,268
-271,482
-84% -$5.45M
T icon
55
AT&T
T
$163B
$930K 0.36%
36,651
+2,337
+7% +$60.6K
STR
56
DELISTED
QUESTAR CORP
STR
$892K 0.34%
35,270
– –
KMPR icon
57
Kemper
KMPR
$1.68B
$867K 0.33%
24,023
-830
-3% -$29.3K
LVLT
58
DELISTED
Level 3 Communications Inc
LVLT
$807K 0.31%
16,338
-133
-0.8% -$6.14K
MRK icon
59
Merck
MRK
$318B
$804K 0.31%
14,833
+314
+2% +$17.5K
TRV icon
60
Travelers Companies
TRV
$80.2B
$804K 0.31%
7,597
– –
JCI icon
61
Johnson Controls International
JCI
$92.2B
$661K 0.25%
13,064
– –
VZ icon
62
Verizon
VZ
$196B
$657K 0.25%
14,037
+2,000
+17% +$97.8K
CDK
63
DELISTED
CDK Global, Inc.
CDK
$571K 0.22%
+14,009
New +$496K
BMY icon
64
Bristol-Myers Squibb
BMY
$132B
$567K 0.22%
9,600
– –
JPM icon
65
JPMorgan Chase
JPM
$950B
$560K 0.21%
8,945
– –
MRSH
66
Marsh
MRSH
$91.5B
$425K 0.16%
7,420
– –
RTX icon
67
RTX Corp
RTX
$301B
$368K 0.14%
5,085
– –
ORCL icon
68
Oracle
ORCL
$423B
$355K 0.14%
7,900
– –
ING icon
69
ING
ING
$102B
$264K 0.1%
20,388
– –
LEG icon
70
Leggett & Platt
LEG
$1.31B
$256K 0.1%
6,000
– –
SPXC icon
71
SPX Corp
SPXC
$10.8B
$221K 0.08%
+10,209
New +$228K
ED icon
72
Consolidated Edison
ED
$39.9B
$218K 0.08%
+3,310
New +$208K
WST icon
73
West Pharmaceutical
WST
$24.9B
$213K 0.08%
+4,000
New +$200K
CBT icon
74
Cabot Corp
CBT
$4.52B
$211K 0.08%
4,800
– –
DNOW icon
75
DNOW Inc
DNOW
$2.99B
– –
-19,195
Closed -$584K
1 2
3

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Thompson Rubinstein Investment Management held 75 positions worth $261M, up 2.7% from $254M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thompson Rubinstein Investment Management's Q4 2014 filing shows 5 new, 17 increased, 28 reduced and 1 closed positions. Its largest new stake was Keysight: 36,115 shares worth $1.22M. The largest sale was Edwards Lifesciences, an estimated $5.45M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Energy.

  • Thompson Rubinstein Investment Management's largest Q4 2014 buy was Keysight: 36,115 shares worth $1.22M.
  • Thompson Rubinstein Investment Management added most to Diamond Offshore Drilling in Q4 2014, an estimated $1.67M increase.
  • Thompson Rubinstein Investment Management's biggest Q4 2014 reduction was Edwards Lifesciences, cutting an estimated $5.45M.
  • Thompson Rubinstein Investment Management fully exited DNOW Inc in Q4 2014, selling an estimated $584K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 39% of its $261M portfolio in Q4 2014.
  • Thompson Rubinstein Investment Management opened 5 new positions and closed 1 in Q4 2014.
  • Thompson Rubinstein Investment Management's portfolio value rose 2.7% quarter-over-quarter to $261M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q4 2014, filed 21 Jan 2015.